Survival of patients treated with extended-hours haemodialysis in Europe: an analysis of the ERA-EDTA Registry

Author:

Jansz Thijs T12ORCID,Noordzij Marlies3,Kramer Anneke3,Laruelle Eric45,Couchoud Cécile6,Collart Frederic7,Cases Aleix89ORCID,Arici Mustafa10,Helve Jaako1112,Waldum-Grevbo Bård13,Rydell Helena1415,Traynor Jamie P16,Zoccali Carmine17,Massy Ziad A1819,Jager Kitty J3,van Jaarsveld Brigit C220

Affiliation:

1. Department of Nephrology and Hypertension, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands

2. Dianet Dialysis Centres, Utrecht, The Netherlands

3. ERA-EDTA Registry, Department of Medical Informatics, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

4. AUB Sante Dialyse, Rennes, France

5. Service de Nephrologie, CHU Rennes, Rennes, France

6. REIN Registry, Agence de la biomédecine, Saint-Denis La Plaine, France

7. French-Belgian ESRD Registry, Brussels, Belgium

8. Nephrology Unit, Hospital Clinic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain

9. Registre de Malalts Renals de Catalunya, Barcelona, Spain

10. Department of Nephrology, Faculty of Medicine, Hacettepe University, Ankara, Turkey

11. Finnish Registry for Kidney Diseases, Helsinki, Finland

12. Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

13. Department of Nephrology, Oslo University Hospital, Ullevål, Norway

14. Department of Clinical Sciences Intervention and Technology, Karolinska Institutet, Huddinge, Sweden

15. Swedish Renal Registry, Department of Internal Medicine, Ryhov County Hospital, Jönköping, Sweden

16. Scottish Renal Registry Meridian Court, Information Services Division Scotland, Glasgow, UK

17. Clinical Epidemiology and Physiopathology of Renal Diseases and Hypertension, CNR-Institute of Clinical Physiology, Reggio Calabria, Italy

18. Division of Nephrology, Ambroise-Paré University Hospital, APHP, University of Paris Ouest-Versailles-St-Quentin-en-Yvelines, Boulogne-Billancourt/Paris, France

19. Institut National de la Santé et de la Recherche Médicale U1018, Team 5, CESP UVSQ, University Paris Saclay, Villejuif, France

20. Department of Nephrology and Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands

Abstract

Abstract Background Previous US studies have indicated that haemodialysis with ≥6-h sessions [extended-hours haemodialysis (EHD)] may improve patient survival. However, patient characteristics and treatment practices vary between the USA and Europe. We therefore investigated the effect of EHD three times weekly on survival compared with conventional haemodialysis (CHD) among European patients. Methods We included patients who were treated with haemodialysis between 2010 and 2017 from eight countries providing data to the European Renal Association–European Dialysis and Transplant Association Registry. Haemodialysis session duration and frequency were recorded once every year or at every change of haemodialysis prescription and were categorized into three groups: CHD (three times weekly, 3.5–4 h/treatment), EHD (three times weekly, ≥6 h/treatment) or other. In the primary analyses we attributed death to the treatment at the time of death and in secondary analyses to EHD if ever initiated. We compared mortality risk for EHD to CHD with causal inference from marginal structural models, using Cox proportional hazards models weighted for the inverse probability of treatment and censoring and adjusted for potential confounders. Results From a total of 142 460 patients, 1338 patients were ever treated with EHD (three times, 7.1 ± 0.8 h/week) and 89 819 patients were treated exclusively with CHD (three times, 3.9 ± 0.2 h/week). Crude mortality rates were 6.0 and 13.5/100 person-years. In the primary analyses, patients treated with EHD had an adjusted hazard ratio (HR) of 0.73 [95% confidence interval (CI) 0.62–0.85] compared with patients treated with CHD. When we attributed all deaths to EHD after initiation, the HR for EHD was comparable to the primary analyses [HR 0.80 (95% CI 0.71–0.90)]. Conclusions EHD is associated with better survival in European patients treated with haemodialysis three times weekly.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3